US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anti-Pandemic Concept

1,408.57

+29.852.17%

Number of Gainers:14

Number of Losers:4

Number of Flat:1

PE:- -

High:1,416.55

Open:1,393.57

Low:1,391.71

Close:1,378.72

Loading ...

Corvus 'Undervalued' Following Atopic Dermatitis Data From Apogee, Mizuho Securities Says

MT Newswires Live

Moderna Shares Rise 9%

THOMSON REUTERS

BRIEF-FDA Says To Discontinue Hospira's Morphine Sulfate, Injection, 10 Mg/1 Ml, 4 Mg/1 Ml, 8 Mg/1 Ml- Website

Moderna Up Nearly 9%, Best Performer in the S&P 500 So Far Today -- Data Talk

FDA: Discontinues Manufacturing of Hospira's Morphine Sulfate, Injection, 10 Mg/1 Ml, 4 Mg/1 Ml, 8 Mg/1 Ml- Website

THOMSON REUTERS

AstraZeneca (AZN) Receives a Hold from Deutsche Bank

Abbott Laboratories Launches FreeStyle Libre 3 Plus Glucose Sensor in Canada

MT Newswires Live

Supplemental New Drug Application Submitted to U.S. FDA for Caplyta® (Lumateperone) With Data Demonstrating Significant Schizophrenia Relapse Prevention Compared to Placebo

THOMSON REUTERS

Abbott's Latest-Generation Freestyle Libre 3 Plus Glucose Sensor Technology Launches in Canada

THOMSON REUTERS

3 Disappointing Blue Chip Stocks That Have Crashed as Much as 87% in 10 Years

Vaxart, Inc. Transitions from NASDAQ to OTCQX, Begins Trading Under Symbol "VXRT

NanoCarrier Advances mRNA Therapy for Osteoarthritis

NANO MRNA Seeks Ethics Approval for Phase 1 Trial of Knee Osteoarthritis Drug

MT Newswires Live

Inovio Pharmaceuticals Inc. to Present at Orphan Drug Summit on Next Gen DNA Medicine for Rare Diseases

Mhra: There Is Small Increase in Risk of Guillain-BarrÉ Syndrome Post Vaccination With Abrysvo and Arexvy in Adults Aged 60 Years & Older -Website

THOMSON REUTERS

UK's Mhra: Currently No Evidence of Increased Risk of Guillain-BarrÉ Syndrome in Pregnant Women Following Vaccination With Abrysvo

THOMSON REUTERS

UK's Mhra: Commission on Human Medicines Advise That Benefits of Vaccination Against Rsv Outweigh Small Risk of Developing Guillain-BarrÉ Syndrome

THOMSON REUTERS

How Australia should respond to Trump’s tariff deadline

The Australian Financial Review

Press Release: ARIS MINING ANNOUNCES SALE OF JUBY GOLD PROJECT TO MCFARLANE LAKE MINING

Inovio Pharmaceuticals Announces Public Offering Agreement

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/BK4568/news?page=8"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"Anti-Pandemic Concept","latestPrice":1408.574,"timestamp":1752695999999,"preClose":1378.7249,"halted":0,"volume":102398821,"delay":0,"changeRate":0.02165,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":29.849121,"latestTime":"07-16 16:00:00 EDT","open":1393.5732,"high":1416.5477,"low":1391.7104,"amount":7025775311.624446,"amplitude":0.018015,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1752739200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":3.703999,"peRate":22.02632,"turnoverRate":0.00669,"increases":14,"decrements":4,"flats":1,"marketCap":1161800906357.75,"floatMarketCap":1140615020001.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1416.5477,"amplitude":0.018015,"preClose":1378.7249,"low":1391.7104,"pbRate":"3.703999","latestPrice":1408.574,"volume":102398821,"delay":0,"open":1393.5732,"prevYearClose":1274.8187,"prevWeekClose":1397.679,"prevMonthClose":1377.5769,"prevQuarterClose":1377.5769,"fiveDayClose":1401.8469,"twentyDayClose":1394.9728,"sixtyDayClose":1341.7848,"secType":"PLATE","market":"US","turnoverRate":0.00669,"peRate":22.02632,"marketCap":1161800906357.75,"floatMarketCap":1140615020001.5,"timestamp":1752695999999,"nameCN":"Anti-Pandemic Concept"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":14,"down":4,"flat":1},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:8,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2549529452","title":"Corvus 'Undervalued' Following Atopic Dermatitis Data From Apogee, Mizuho Securities Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2549529452","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549529452?lang=en_us&edition=fundamental","pubTime":"2025-07-08 23:30","pubTimestamp":1751988659,"startTime":"0","endTime":"0","summary":"Corvus Pharmaceuticals (CRVS) stock remains \"undervalued and compelling\" compared with peers like Apogee Therapeutics (APGE), whose latest data on its experimental atopic dermatitis drug APG777 failed","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","APGE","MFG","BK4568","BK4207","CRVS"],"gpt_icon":0},{"id":"2549523074","title":"Moderna Shares Rise 9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2549523074","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549523074?lang=en_us&edition=fundamental","pubTime":"2025-07-08 22:24","pubTimestamp":1751984672,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"73b1e1ef24d3e075fd9045c0caf14e96","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nL4N3T511R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NVAX","BK4548","BK4532","BK4585","BK4588","MRNA","BK4547","BK4534","BK4501","BK4139","BK4533","BK4551","BK4568"],"gpt_icon":0},{"id":"2549006523","title":"BRIEF-FDA Says To Discontinue Hospira's Morphine Sulfate, Injection, 10 Mg/1 Ml, 4 Mg/1 Ml, 8 Mg/1 Ml- Website","url":"https://stock-news.laohu8.com/highlight/detail?id=2549006523","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549006523?lang=en_us&edition=fundamental","pubTime":"2025-07-08 22:24","pubTimestamp":1751984667,"startTime":"0","endTime":"0","summary":"BRIEF-FDA Says To Discontinue Hospira's Morphine Sulfate, Injection, 10 Mg/1 Ml, 4 Mg/1 Ml, 8 Mg/1 Ml- WebsiteJuly 8  - FDA:FDA: DISCONTINUES MANUFACTURING OF HOSPIRA'S MORPHINE SULFATE, INJECTION, 10 MG/1 ML, 4 MG/1 ML, 8 MG/1 ML- WEBSITEFurther company coverage: PFE.N ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nFWN3T50F3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225771236.USD","LU0456855351.SGD","LU0868494617.USD","BK4581","LU1894683348.USD","LU0321505868.SGD","LU0225284248.USD","BK4550","IE00BBT3K403.USD","IE00BLSP4452.SGD","LU0122379950.USD","LU1894683264.USD","LU1066051498.USD","LU0058720904.USD","PFE","IE00BLSP4239.USD","BK4007","LU0306806265.USD","LU0289739699.SGD","SG9999001176.USD","IE00B19Z3581.USD","SG9999001176.SGD","LU1883839398.USD","IE00B19Z3B42.SGD","LU1057294990.SGD","LU1066053197.SGD","BK4588","LU1023059063.AUD","BK4585","LU0170899867.USD","SG9999002224.SGD","LU0306807586.USD","LU0321505439.SGD","SG9999002232.USD","SG9999003800.SGD","IE000M9KFDE8.USD","IE0002270589.USD","SGXZ57979304.SGD","BK4534","BK4533","BK4592","BK4568","BK4599","SG9999011175.SGD","SG9999013999.USD","LU0234572021.USD","LU0985481810.HKD"],"gpt_icon":0},{"id":"2549652309","title":"Moderna Up Nearly 9%, Best Performer in the S&P 500 So Far Today -- Data Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2549652309","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549652309?lang=en_us&edition=fundamental","pubTime":"2025-07-08 22:23","pubTimestamp":1751984580,"startTime":"0","endTime":"0","summary":"Moderna, Inc.  is currently at $32.57, up $2.67 or 8.93%. --Would be highest close since March 25, 2025, when it closed at $33.85. --On pace for largest percent increase since March 5, 2025, when it rose 15.94%. --Down 93.28% from its all-time closing high of $484.47 on Aug. 9, 2021. --Down 71.94% from 52 weeks ago , when it closed at $116.07. --Down 73.97% from its 52-week closing high of $125.14 on July 16, 2024. --Up 37.72% from its 52-week closing low of $23.65 on May 15, 2025. --Up 8.93% at today's intraday high; largest intraday percent increase since May 20, 2025, when it rose as much as 14.82%","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4533","SDS","BK4588","BK4504","BK4551","BK4532","OEX","BK4550","SH","BK4559","SSO","BK4501","BK4581","OEF","SPXU","BK4548","UPRO","ESmain","BK4534","VOO","MESmain","BK4568",".SPX","BK4585","BK4139","SPY","IVV","MRNA"],"gpt_icon":0},{"id":"2549477528","title":"FDA: Discontinues Manufacturing of Hospira's Morphine Sulfate, Injection, 10 Mg/1 Ml, 4 Mg/1 Ml, 8 Mg/1 Ml- Website","url":"https://stock-news.laohu8.com/highlight/detail?id=2549477528","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549477528?lang=en_us&edition=fundamental","pubTime":"2025-07-08 21:53","pubTimestamp":1751982839,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nFWN3T50F3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0985481810.HKD","BK4533","LU1057294990.SGD","SG9999003800.SGD","LU0289739699.SGD","LU0306806265.USD","BK4534","BK4585","IE00BLSP4239.USD","BK4581","LU1023059063.AUD","PFE","BK4588","BK4550","SG9999001176.USD","LU1066051498.USD","IE00BBT3K403.USD","BK4007","IE0002270589.USD","IE00B19Z3581.USD","IE00B19Z3B42.SGD","LU0234572021.USD","LU0122379950.USD","BK4592","IE00BLSP4452.SGD","SG9999002224.SGD","BK4599","IE000M9KFDE8.USD","SGXZ57979304.SGD","SG9999002232.USD","LU0868494617.USD","LU0306807586.USD","LU0225284248.USD","LU1066053197.SGD","SG9999001176.SGD","LU0170899867.USD","SG9999011175.SGD","LU0321505868.SGD","LU1894683264.USD","LU1894683348.USD","SG9999013999.USD","LU0456855351.SGD","LU1883839398.USD","LU0058720904.USD","BK4568","LU0225771236.USD","LU0321505439.SGD"],"gpt_icon":0},{"id":"2549540893","title":"AstraZeneca (AZN) Receives a Hold from Deutsche Bank","url":"https://stock-news.laohu8.com/highlight/detail?id=2549540893","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549540893?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:55","pubTimestamp":1751979329,"startTime":"0","endTime":"0","summary":"Deutsche Bank analyst Emmanuel Papadakis reiterated a Hold rating on AstraZeneca today and set a price target of p11,000.00. The company’s shares o...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-receives-a-hold-from-deutsche-bank-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/astrazeneca-azn-receives-a-hold-from-deutsche-bank-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AZN","BK4552","DB","BK4118","LU0889565916.HKD","LU2417539215.USD","LU1829250122.USD","LU2462157665.USD","BK4566","BK4588","BK4007","LU2236285917.USD","BK4585","BK4568","LU2456880835.USD","LU0320765992.SGD","LU0109394709.USD"],"gpt_icon":0},{"id":"2549542075","title":"Abbott Laboratories Launches FreeStyle Libre 3 Plus Glucose Sensor in Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2549542075","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549542075?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:46","pubTimestamp":1751978783,"startTime":"0","endTime":"0","summary":"Abbott Laboratories (ABT) said Tuesday that the latest generation of its continuous glucose monitoring device, the FreeStyle Libre 3 Plus sensor, is now available in Canada.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2468319806.SGD","LU0266013472.USD","BK4082","BK4566","LU0234572021.USD","LU1061106388.HKD","LU1989763427.SGD","LU1691799644.USD","LU2133065610.SGD","LU1989763690.USD","LU0122379950.USD","LU1057294990.SGD","SG9999004303.SGD","IE00B2B36J28.USD","LU0170899867.USD","LU1721429741.USD","LU2112291526.USD","BK4592","IE0002141913.USD","SGXZ23171101.USD","BK4581","LU1721429402.USD","BK4585","IE00BJT1NW94.SGD","LU1023059063.AUD","LU2089984988.USD","ABT.AU","LU2237957811.SGD","IE00BFTCPJ56.SGD","SG9999002232.USD","LU1914381329.SGD","LU0868494617.USD","BK4533","BK4504","ABT","LU2237957902.USD","IE0009355771.USD","SG9999002224.SGD","IE00B4R5TH58.HKD","BK4568","IE00BJJMRZ35.SGD","BK4588"],"gpt_icon":0},{"id":"2549544304","title":"Supplemental New Drug Application Submitted to U.S. FDA for Caplyta® (Lumateperone) With Data Demonstrating Significant Schizophrenia Relapse Prevention Compared to Placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2549544304","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549544304?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:00","pubTimestamp":1751976008,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nTUA9VDGFB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B42XCP33.USD","LU1244550494.USD","BK4007","IE00BN8TJ469.HKD","LU1162221912.USD","LU1032466523.USD","BK4550","LU0345770308.USD","IE00BFTCPJ56.SGD","LU2347655156.SGD","LU2430703178.SGD","IE0002141913.USD","LU2129689605.HKD","LU1221951046.USD","BK4592","LU0098860793.USD","JNJ","IE00BGHQF631.EUR","LU0985320562.USD","LU1929549753.HKD","LU1196500208.SGD","LU0640476718.USD","LU2133065610.SGD","BK4581","LU1061106388.HKD","LU0203345920.USD","LU1066051225.USD","SG9999002224.SGD","IE00BFXG1179.USD","IE0009355771.USD","LU1894683348.USD","LU1894683264.USD","LU0466842654.USD","LU1585245621.USD","IE000M9KFDE8.USD","LU0795875169.SGD","LU2089984988.USD","IE0002270589.USD","BK4588","IE00B3PB1722.GBP","LU0058720904.USD","LU2505996509.AUD","LU1674673691.USD","LU2592432038.USD","IE00BLSP4239.USD","IE00BLSP4452.SGD","BK4568","BK4532","IE00BVYPNW00.USD","LU0122379950.USD"],"gpt_icon":0},{"id":"2549054437","title":"Abbott's Latest-Generation Freestyle Libre 3 Plus Glucose Sensor Technology Launches in Canada","url":"https://stock-news.laohu8.com/highlight/detail?id=2549054437","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549054437?lang=en_us&edition=fundamental","pubTime":"2025-07-08 20:00","pubTimestamp":1751976006,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nTUA88XLW0:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1721429402.USD","BK4592","LU0868494617.USD","LU0122379950.USD","IE00BFTCPJ56.SGD","BK4533","LU2089984988.USD","BK4588","LU1061106388.HKD","LU2237957811.SGD","BK4082","LU1914381329.SGD","IE00BJJMRZ35.SGD","LU1989763690.USD","BK4504","IE00B4R5TH58.HKD","LU1691799644.USD","SGXZ23171101.USD","BK4585","SG9999002224.SGD","LU0266013472.USD","LU1721429741.USD","SG9999002232.USD","IE00BJT1NW94.SGD","LU2468319806.SGD","IE0002141913.USD","IE00B2B36J28.USD","LU2112291526.USD","LU1989763427.SGD","ABT","LU1057294990.SGD","LU0234572021.USD","BK4568","BK4566","BK4581","LU2133065610.SGD","LU2237957902.USD","SG9999004303.SGD","IE0009355771.USD","LU1023059063.AUD","LU0170899867.USD"],"gpt_icon":0},{"id":"2549419125","title":"3 Disappointing Blue Chip Stocks That Have Crashed as Much as 87% in 10 Years","url":"https://stock-news.laohu8.com/highlight/detail?id=2549419125","media":"Motley Fool","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549419125?lang=en_us&edition=fundamental","pubTime":"2025-07-08 19:32","pubTimestamp":1751974320,"startTime":"0","endTime":"0","summary":"These stocks have all fallen between 19% and 87% over the past decade.Changing market conditions and consumer tastes and preferences have weighed on these businesses.Investors can learn a lot from their downfalls.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fool.com/investing/2025/07/08/3-disappointing-blue-chip-stocks-that-have-crashed/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fool_stock","symbols":["LU1066053197.SGD","IE00B19Z3581.USD","BK4599","BK4533","LU0225284248.USD","BK4007","LU1894683264.USD","LU1066051498.USD","SG9999013999.USD","LU0321505439.SGD","BK4592","LU1023059063.AUD","LU0306807586.USD","LU0122379950.USD","SG9999011175.SGD","SG9999003800.SGD","LU0234572021.USD","IE00B19Z3B42.SGD","SG9999002224.SGD","BK4550","LU1894683348.USD","SG9999002232.USD","LU0321505868.SGD","PFE","LU0289739699.SGD","BK4534","LU0985481810.HKD","BK4585","IE00BLSP4239.USD","LU0058720904.USD","SG9999001176.SGD","IE00BBT3K403.USD","BK4581","LU0306806265.USD","LU1883839398.USD","LU1057294990.SGD","LU0170899867.USD","LU0456855351.SGD","IE0002270589.USD","BK4568","BK4588","IE00BLSP4452.SGD","LU0225771236.USD","LU0868494617.USD","SG9999001176.USD","SGXZ57979304.SGD","IE000M9KFDE8.USD"],"gpt_icon":1},{"id":"2549549340","title":"Vaxart, Inc. Transitions from NASDAQ to OTCQX, Begins Trading Under Symbol \"VXRT","url":"https://stock-news.laohu8.com/highlight/detail?id=2549549340","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549549340?lang=en_us&edition=fundamental","pubTime":"2025-07-08 19:00","pubTimestamp":1751972429,"startTime":"0","endTime":"0","summary":"OTC Markets Group Inc. has announced that Vaxart, Inc., a clinical-stage biotechnology company, has qualified to trade on the OTCQX Best Market. Previously listed on NASDAQ, Vaxart, Inc. will now trade under the symbol \"VXRT\" on the OTCQX Market. The transition aims to provide the company with efficient and cost-effective access to U.S. capital markets while offering transparent trading for investors. Vaxart's CEO, Steven Lo, expressed gratitude towards OTC Markets Group and the company's investors, emphasizing their commitment to advancing oral pill vaccines to enhance public health.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OTC Markets Group Inc. published the original content used to generate this news brief via GlobeNewswire  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250708:nNDLbMqCWk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","NDAQ","IE00BKPKM429.USD","IE00BGHQF748.EUR","OTCM","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","BK4139","LU2095319765.USD","BK4568","BK4588","VXRT","BK4585","LU2210149790.SGD","BK4112"],"gpt_icon":0},{"id":"2549907315","title":"NanoCarrier Advances mRNA Therapy for Osteoarthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2549907315","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549907315?lang=en_us&edition=fundamental","pubTime":"2025-07-08 14:55","pubTimestamp":1751957737,"startTime":"0","endTime":"0","summary":"NanoCarrier Co., Ltd. ( ($JP:4571) ) has provided an update. NanoCarrier Co., Ltd., through its subsidiary NANO MRNA Co., Ltd., is advancing in the...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/nanocarrier-advances-mrna-therapy-for-osteoarthritis?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/nanocarrier-advances-mrna-therapy-for-osteoarthritis?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4551","BK4501","BK4532","BK4568","NANO","BK4585","BK4533","BK4548","BK4588","BK4139","BK4534"],"gpt_icon":0},{"id":"2549905665","title":"NANO MRNA Seeks Ethics Approval for Phase 1 Trial of Knee Osteoarthritis Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2549905665","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549905665?lang=en_us&edition=fundamental","pubTime":"2025-07-08 14:46","pubTimestamp":1751957207,"startTime":"0","endTime":"0","summary":"NANO MRNA (TYO:4571) said its Australian unit, PrimRNA AU, has submitted a Phase 1 clinical trial plan for its mRNA-based osteoarthritis drug RUNX1 mRNA to the Human Research Ethics Committees, accord","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","BK4534","BK4568","BK4585","BK4501","NANO","BK4532","BK4533","BK4139","BK4548","BK4551"],"gpt_icon":1},{"id":"2549557769","title":"Inovio Pharmaceuticals Inc. to Present at Orphan Drug Summit on Next Gen DNA Medicine for Rare Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2549557769","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549557769?lang=en_us&edition=fundamental","pubTime":"2025-07-08 04:05","pubTimestamp":1751918741,"startTime":"0","endTime":"0","summary":"Inovio Pharmaceuticals Inc.  is set to present at the Orphan Drug Summit in Boston, Massachusetts, on July 16. The biotechnology company will discuss the potential of next generation DNA medicine technology in rare diseases during their presentation titled \"DMAb Technology: The Transformational Potential of Next Gen DNA Medicine in Rare Disease.\". Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inovio Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire  on July 07, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nNDL2KwvQg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4139","BK4568","INO"],"gpt_icon":0},{"id":"2549705530","title":"Mhra: There Is Small Increase in Risk of Guillain-BarrÉ Syndrome Post Vaccination With Abrysvo and Arexvy in Adults Aged 60 Years & Older -Website","url":"https://stock-news.laohu8.com/highlight/detail?id=2549705530","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549705530?lang=en_us&edition=fundamental","pubTime":"2025-07-07 21:45","pubTimestamp":1751895932,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nFWN3T407J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999001176.USD","LU1481599808.USD","BK4534","LU1066051498.USD","LU1035777561.USD","IE00B19Z3B42.SGD","BK4568","IE0034235071.USD","LU1098665638.USD","LU0306806265.USD","LU1228905540.USD","LU1023059063.AUD","BK4550","LU0321505439.SGD","IE00BLSP4239.USD","GSK.UK","LU1057294990.SGD","BK4007","BK4581","LU0575583348.USD","LU0456855351.SGD","LU1064927863.SGD","IE00BBT3K403.USD","LU0058720904.USD","LU1883839398.USD","LU1202635105.USD","BK4599","BK4585","IE0002270589.USD","LU1894683348.USD","SG9999002224.SGD","LU1400636491.USD","LU0203347892.USD","LU0289739699.SGD","LU0306807586.USD","PFE","SG9999001176.SGD","LU1046248800.SGD","LU1015430645.USD","LU1400636657.SGD","BK4533","LU0225771236.USD","LU1487256676.USD","LU1066053197.SGD","SG9999002232.USD","IE000M9KFDE8.USD","IE00BQJZX424.USD","IE00BWDBJ516.SGD","LU0985481810.HKD","IE00BLSP4452.SGD"],"gpt_icon":0},{"id":"2549530019","title":"UK's Mhra: Currently No Evidence of Increased Risk of Guillain-BarrÉ Syndrome in Pregnant Women Following Vaccination With Abrysvo","url":"https://stock-news.laohu8.com/highlight/detail?id=2549530019","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549530019?lang=en_us&edition=fundamental","pubTime":"2025-07-07 21:45","pubTimestamp":1751895932,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nFWN3T407J:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0868494617.USD","IE00BWDBJ516.SGD","BK4581","LU1015430645.USD","LU1894683348.USD","BK4550","IE00BLSP4452.SGD","LU0971552830.HKD","LU0122379950.USD","LU0575583348.USD","LU1894683264.USD","LU0058720904.USD","LU1302929846.USD","LU1202635105.USD","PFE","GSK.UK","IE00BLSP4239.USD","LU1046248800.SGD","LU0545562505.USD","BK4007","LU0306806265.USD","LU0971552673.USD","SG9999001176.USD","IE00B19Z3581.USD","LU1400636657.SGD","LU0203345920.USD","LU1057294990.SGD","LU1066053197.SGD","BK4588","BK5011","LU1228905037.USD","BK4585","LU0170899867.USD","SG9999002224.SGD","LU0321505439.SGD","LU1228905540.USD","IE000M9KFDE8.USD","LU1487256676.USD","SGXZ57979304.SGD","BK4534","IE00BQJZX424.USD","BK4533","BK4592","LU1645745479.HKD","BK4568","SG9999013999.USD","SG9999011175.SGD","LU1098665638.USD","LU1481600234.SGD","LU0985481810.HKD"],"gpt_icon":0},{"id":"2549530012","title":"UK's Mhra: Commission on Human Medicines Advise That Benefits of Vaccination Against Rsv Outweigh Small Risk of Developing Guillain-BarrÉ Syndrome","url":"https://stock-news.laohu8.com/highlight/detail?id=2549530012","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549530012?lang=en_us&edition=fundamental","pubTime":"2025-07-07 21:45","pubTimestamp":1751895932,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250707:nFWN3T407J:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1487256676.USD","LU0971552830.HKD","LU1894683264.USD","PFE","BK4534","BK4585","IE00BWDBJ516.SGD","LU0321505439.SGD","LU1202635105.USD","LU1057294990.SGD","IE00B19Z3581.USD","SGXZ57979304.SGD","BK4568","LU0170899867.USD","LU1481600234.SGD","BK4592","LU1645745479.HKD","LU1302929846.USD","SG9999001176.USD","LU0203345920.USD","LU0545562505.USD","LU0868494617.USD","LU1066053197.SGD","IE000M9KFDE8.USD","LU1098665638.USD","LU0971552673.USD","LU1400636657.SGD","LU0575583348.USD","BK4007","LU0985481810.HKD","LU1228905037.USD","BK5011","LU0058720904.USD","GSK.UK","BK4581","LU1046248800.SGD","LU1228905540.USD","SG9999011175.SGD","BK4550","BK4533","IE00BLSP4239.USD","SG9999002224.SGD","BK4588","LU0122379950.USD","LU1015430645.USD","LU1894683348.USD","SG9999013999.USD","IE00BQJZX424.USD","IE00BLSP4452.SGD","LU0306806265.USD"],"gpt_icon":0},{"id":"2549537009","title":"How Australia should respond to Trump’s tariff deadline","url":"https://stock-news.laohu8.com/highlight/detail?id=2549537009","media":"The Australian Financial Review","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549537009?lang=en_us&edition=fundamental","pubTime":"2025-07-07 20:30","pubTimestamp":1751891400,"startTime":"0","endTime":"0","summary":"With the temporary pause on proposed US tariff hikes set to expire on Wednesday, the world’s economies are bracing themselves for whatever comes next.Rapid and wide-ranging changes to US trade policy have already seen economic uncertainty reach its highest levels since COVID-19.Loading...","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.afr.com/policy/economy/how-australia-should-respond-to-trump-s-tariff-deadline-20250707-p5mcyv","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"afr_stock","symbols":["BK4535","BK4139","BNTX","BK4568","XAO.AU","BK4588","BK4548","XKO.AU","XJO.AU","BK4551","BK4585"],"gpt_icon":0},{"id":"2549342435","title":"Press Release: ARIS MINING ANNOUNCES SALE OF JUBY GOLD PROJECT TO MCFARLANE LAKE MINING","url":"https://stock-news.laohu8.com/highlight/detail?id=2549342435","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549342435?lang=en_us&edition=fundamental","pubTime":"2025-07-07 20:15","pubTimestamp":1751890500,"startTime":"0","endTime":"0","summary":"VANCOUVER, BC and TORONTO, July 7, 2025 /CNW/ - Aris Mining Corporation    and McFarlane Lake Mining Limited    are pleased to announce the signing of a definitive asset purchase agreement  for the sale of Aris Mining's Juby Gold Project and related interests in Ontario, Canada. The total consideration is valued at US$22 million, payable as outlined below.The Juby Gold Project is an exploration-stage gold project located in the Shining Tree area of Ontario's Abitibi greenstone belt. The transaction includes Aris Mining's 100% interest in the Juby Gold Project and its 25% joint venture interest in the adjacent Knight property.Mark Trevisiol, CEO and Chairman of McFarlane, added \"Our team is very excited to be working with Aris Mining on the acquisition of the Juby Gold asset. The addition of this project to McFarlane's portfolio will be accretive to our business and ultimately shareholder value. This acquisition transforms our junior gold exploration company into a gold exploration and ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0630314457.HKD","LU0330918003.SGD","LU0345770993.USD","ARMN","LU0055631609.USD","LU1223082196.USD","IE00B19Z4B17.USD","BK4017","LU0345770308.USD","LU0788108826.HKD","LU1878469433.USD","BK4532","BK4588","LU0496367417.USD","IE0031619046.USD","LU1023059493.AUD","1OZmain","LU0345780950.USD","IE00B7SZL793.SGD","BK4570","IE00B66KJ199.SGD","LU0368265764.SGD","LU0345781412.USD","BK4179","LU0345780281.USD","LU0345780521.USD","BK4585","SG9999001143.SGD","LAKE","LU0724618789.USD","LU0075056555.USD","BK4120","BK4202","LU1223083913.SGD","LU0498741890.SGD","BK4568","LU0498741114.HKD","ARIS","GOLD"],"gpt_icon":0},{"id":"2549753103","title":"Inovio Pharmaceuticals Announces Public Offering Agreement","url":"https://stock-news.laohu8.com/highlight/detail?id=2549753103","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2549753103?lang=en_us&edition=fundamental","pubTime":"2025-07-07 19:55","pubTimestamp":1751889330,"startTime":"0","endTime":"0","summary":"Inovio Pharmaceuticals ( ($INO) ) has shared an announcement. On July 2, 2025, INOVIO Pharmaceuticals entered into an underwriting agreement with P...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/inovio-pharmaceuticals-announces-public-offering-agreement?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/inovio-pharmaceuticals-announces-public-offering-agreement?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4568","INO","BK4583"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}]}}